Home Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development By - March 15, 2024 40 0 Facebook Twitter Pinterest WhatsApp The Israel-based company is the result of AION Labs’ fifth startup challenge. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Smart sanitation robot in South Korea calculates virus spread in closed spaces Pilots - February 9, 2022 0 Study flags safety risks with Australian prescription apps Pilots - March 20, 2023 0 Investment firm Seae Ventures acquires fellow VC firm Unseen Capital Pilots - July 11, 2024 0 Sanofi taps Exscientia for a deal worth up to $5.2B Pilots - January 11, 2022 0 Novosound locks down patent for wearable ultrasound imaging platform Pilots - March 26, 2024 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3